Mosaic Brain - New Diagnostic Approach in Focal Epilepsies
Research type
Research Study
Full title
The Mosaic Brain: A new diagnostic approach in focal epilepsies
IRAS ID
340917
Contact name
Martin Tisdall
Contact email
Sponsor organisation
UCL GOS ICH
Duration of Study in the UK
2 years, 1 months, 1 days
Research summary
Epilepsy is characterised by recurrent epileptic seizures, and is the most common brain disease affecting children, significantly reducing their quality of life. Understanding the cause of epilepsy is key, as it can help doctors to identify the most effective treatment. This is an urgent issue as 30% of all children with epilepsy do not respond to currently available treatments.
In some children, seizures can start in an area of abnormal brain structure which can be removed with epilepsy surgery.
We see 150 children a year with epilepsy suspected to be caused by a brain lesion. As part of their evaluation, we do genetic testing in blood, as we know that changes in their DNA (mutations) can cause epilepsy in 30-40% of children.
It is now known that mutations are found in some areas of brain responsible for seizures but these are not present in the blood. This is mosaicism, when genetic variation affects only a subgroup of cells or tissues in an individual. Understanding these genetic changes in the brain tissue will help us understand how epilepsy starts and may help us design new treatments. Recently, we designed a new genetic test to pick up these mosaic mutations in brain tissue. However, current methods to detect mosaicism require the use of brain tissue, which limits testing to those children who qualify for surgery.
To expand testing to more children, without the need for surgery, we want to focus our work in using alternative samples, such as cell-free DNA cerebrospinal fluid (CSF) and trace-tissue DNA from trace cells collected from Stereoelectroencephalography (SEEG) electrodes.
We aim to further our understanding of brain mosaicism in epilepsy, using the current available tests, as well as aim to increase access to testing by developing methods to use samples collected using less invasive and pre-surgical methods.REC name
London - Bloomsbury Research Ethics Committee
REC reference
24/LO/0543
Date of REC Opinion
6 Sep 2024
REC opinion
Further Information Favourable Opinion